NIMISHA JACOB: Open Payments
NPI 1780458331 · ARLINGTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$796 in 44 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $173 · 2025 $796
Food & beverage: $796
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $161 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $90 |
| Lilly USA, LLC | 4 | $79 |
| Exact Sciences Corporation | 5 | $76 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $74 |
| Astellas Pharma US Inc | 4 | $72 |
| GlaxoSmithKline, LLC. | 3 | $72 |
| AstraZeneca Pharmaceuticals LP | 3 | $52 |
| PFIZER INC. | 2 | $36 |
| Avvisto Therapeutics, LLC | 2 | $34 |
Products named: JARDIANCE, Kerendia, The Cologuard Plus Collection Kit, Veozah, TRELEGY ELLIPTA, CYCLOSET, AIRSUPRA, Wegovy.
Industry payments across TX — which companies pay providers there.
